In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Ascendis Pharma (ASND – Research Report), with a price target of $175.00. The company’s shares closed ...

This is the second successful treatment in a donkey, demonstrating the potential of Innocan's Liposomal CBD injection for human and veterinary use HERZLIYA, Israel and CALGARY, AB, Feb. 10, 2025 ...

“There should be no cooling off from digital transformation in 2021, and all the signs are that key stakeholders are firmly focused on the possibilities that health tech can offer.” Pharma’s ...

The stakes are clear. Research projects that generative AI could boost the pharma and medical-product industries' annual revenues by up to $110 billion by streamlining the resource- and time ...

Commissions do not affect our editors' opinions or evaluations. The best no-fee checking account is Axos Bank Rewards Checking, which scored 4.8 stars (out of a possible 5) thanks to its ...

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo The U.S. Food and Drug Administration ...

A notable potential in Russia and recovering Africa market further bolster optimism. India's pharma sector has seen remarkable growth in exports, with 99% target already being achieved before FY25, ...

Sanofi S.A. Part Cert 0.02% €8.03M ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 17,464.11 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Companies that have grown profits and net profit margins over the past 12 months ...